Edition:
United States

ARYx Therapeutics Inc (ARYX.PK)

ARYX.PK on OTC Markets Group

0.00USD
10:56am EST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.00
Open
$0.00
Day's High
$0.00
Day's Low
$0.00
Volume
52,233
Avg. Vol
42,983
52-wk High
$0.01
52-wk Low
$0.00

ARYX.PK

Chart for ARYX.PK

About

ARYx Therapeutics, Inc. is a United States-based pharmaceutical Company. The Company is developing a proprietary portfolio of patient-targeted, first-in-class monoclonal antibodies designed to treat seriously ill patients with difficult-to-treat diseases. It is engaged in retrometabolic drug design that focuses on the safety of... (more)
No analyst recommendations are available for ARYX.PK.

Overall

Beta: -4.63
Market Cap(Mil.): $0.13
Shares Outstanding(Mil.): 33.46
Dividend: --
Yield (%): --

Financials

  ARYX.PK Industry Sector
P/E (TTM): -- 29.93 30.76
EPS (TTM): -0.61 -- --
ROI: -487.55 15.46 14.89
ROE: -- 16.64 16.30

Competitors

  Price Chg
Johnson & Johnson (JNJ.N) $114.48 -0.22
Pfizer Inc. (PFE.N) $31.80 -0.23
Novartis AG (NOVN.S) CHF71.10 -1.10
Sanofi SA (SASY.PA) €75.77 -0.73
AstraZeneca plc (AZN.L) 4,468.50 -112.00
Bayer AG (BAYGn.DE) €101.90 -0.10
Bayer AG (BAYE.F) -- --
3M Co (MMM.N) $178.92 +0.43
Bristol-Myers Squibb Co (BMY.N) $55.60 -0.47
Bristol-Myers Squibb Co (BMYMP.PK) $997.31 --

Earnings vs. Estimates